Rivanicline
From Wikipedia, the free encyclopedia
Jump to: navigation, search
![]() |
|
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
|
|
CAS Number | 15585-43-0 ![]() 538-79-4 (Mixture E of Z) |
PubChem (CID) | 5310967 |
IUPHAR/BPS | 3994 |
ChemSpider | 4470511 ![]() |
UNII | 6H35LF645A ![]() |
Chemical and physical data | |
Formula | C10H14N2 |
Molar mass | 162.232 |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
Rivanicline (TC-2403, RJR-2403, (E)-metanicotine) is a drug which acts as a partial agonist at neural nicotinic acetylcholine receptors. It is subtype-selective, binding primarily to the α4β2 subtype. It has nootropic effects and was originally developed as a potential treatment for Alzheimer's disease,[1][2] but a second action that was subsequently found was that it inhibits the production of Interleukin-8 and thus produces an antiinflammatory effect, and so it has also been developed as a potential treatment for ulcerative colitis.[3] Rivanicline also has stimulant and analgesic actions which are thought to be mediated through stimulation of noradrenaline release,[4] and so it could potentially also have other applications.
References[edit]
- ^ Jang J, Sin KS, Park H. Synthesis of (+/-)-methyl-(1-aryl-4-pyridin-3-yl-but-3-enyl)-amines. Archives of Pharmacal Research. 2001 Dec;24(6):503-7. PMID 11794523
- ^ Sapronov NS, Fedotova YO, Kuznetsova NN. Antiamnestic effect of alpha7-nicotinic receptor agonist RJR-2403 in middle-aged ovariectomized rats with Alzheimer type dementia. Bulletin of Experimental Biology and Medicine. 2006 Dec;142(6):700-2. PMID 17603674
- ^ Spoettl T, Paetzel C, Herfarth H, Bencherif M, Schoelmerich J, Greinwald R, Gatto GJ, Rogler G. (E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa. International Journal of Colorectal Disease. 2007 Mar;22(3):303-12. PMID 16715250
- ^ Li X, Eisenach JC. Nicotinic acetylcholine receptor regulation of spinal norepinephrine release. Anesthesiology. 2002 Jun;96(6):1450-6. PMID 12170059
Opioids | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paracetamol-type | |||||||||||||||||||||||||||||||
NSAIDs |
|
||||||||||||||||||||||||||||||
Cannabinoids | |||||||||||||||||||||||||||||||
Ion channel modulators |
|
||||||||||||||||||||||||||||||
Myorelaxants | |||||||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||||||
|
AChE inhibitors | |
---|---|
Others |
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Pages using PMID magic links
- Articles with changed CASNo identifier
- Articles with changed ChemSpider identifier
- Articles with changed InChI identifier
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- All stub articles